Sturge-weber syndrome
- PMID: 23907585
- PMCID: PMC4487908
- DOI: 10.1007/s11940-013-0253-6
Sturge-weber syndrome
Abstract
We try to see the babies prior to the onset of symptoms so that their parents can receive anticipatory guidance regarding seizures and how to recognize and respond to them and so that proper referrals to ophthalmology can be made. If there is any concern on history, exam, or EEG then we obtain a magnetic resonance imaging (MRI) with contrast. If presymptomatic diagnosis of brain involvement is made then treatment with low-dose aspirin is offered and if the brain involvement is extensively bilateral then an anticonvulsant such as levetiracetam is offered as well. Seizures are treated aggressively with a goal of obtaining and maintaining complete seizure suppression as much as possible often with a combination of low-dose aspirin and two anticonvulsants such as levetiracetam and oxcarbazepine. For many patients, this will provide adequate control of their seizures and stroke-like episodes. If the patient fails medical management and seizures are regular and accompanied by plateaued development, significant hemiparesis and visual field deficit and the patient is unilaterally involved and a surgical candidate then surgical management is urged. When the seizures are less regular, little or no hemiparesis or visual field deficit exist, and development is reasonable then this decision is more difficult. For bilaterally involved patients surgery is usually not a good option unless seizures are very severe and mostly coming from one side. Other therapeutic options include the ketogenic/Atkins diet and vagal nerve stimulator although in our experience these usually do not result in cessation of seizures. Endocrine problems occur with increased frequency and must be treated when they are present. The recent discovery of the somatic mutation causing Sturge-Weber syndrome holds promise for new treatment options in the future.
Conflict of interest statement
Anne M. Comi has two patents pending regarding the GNAQ gene mutation and potential treatment approaches based on this mechanism.
Catherine D. Bachur declares that she has no conflict of interest.
Similar articles
-
Anticonvulsant Efficacy in Sturge-Weber Syndrome.Pediatr Neurol. 2016 May;58:31-6. doi: 10.1016/j.pediatrneurol.2015.10.015. Epub 2016 Jan 11. Pediatr Neurol. 2016. PMID: 26997037 Free PMC article.
-
Current Therapeutic Options in Sturge-Weber Syndrome.Semin Pediatr Neurol. 2015 Dec;22(4):295-301. doi: 10.1016/j.spen.2015.10.005. Epub 2015 Nov 11. Semin Pediatr Neurol. 2015. PMID: 26706016 Free PMC article. Review.
-
Retrospective Analysis of Presymptomatic Treatment In Sturge-Weber Syndrome.Ann Child Neurol Soc. 2024 Mar;2(1):60-72. doi: 10.1002/cns3.20058. Epub 2024 Jan 10. Ann Child Neurol Soc. 2024. PMID: 38745912 Free PMC article.
-
Updates on Sturge-Weber Syndrome.Stroke. 2022 Dec;53(12):3769-3779. doi: 10.1161/STROKEAHA.122.038585. Epub 2022 Oct 20. Stroke. 2022. PMID: 36263782 Free PMC article. Review.
-
Vesicoureteral Reflux.2024 Apr 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Apr 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 33085409 Free Books & Documents.
Cited by
-
Sturge-Weber syndrome secondary glaucoma: From Pathogenesis to Treatment.Eye Vis (Lond). 2025 Apr 17;12(1):16. doi: 10.1186/s40662-025-00432-6. Eye Vis (Lond). 2025. PMID: 40241121 Free PMC article. Review.
-
Sturge-Weber Syndrome: A Case Report.JNMA J Nepal Med Assoc. 2023 Nov 1;61(267):890-892. doi: 10.31729/jnma.8344. JNMA J Nepal Med Assoc. 2023. PMID: 38289732 Free PMC article.
-
Anticonvulsant Efficacy in Sturge-Weber Syndrome.Pediatr Neurol. 2016 May;58:31-6. doi: 10.1016/j.pediatrneurol.2015.10.015. Epub 2016 Jan 11. Pediatr Neurol. 2016. PMID: 26997037 Free PMC article.
-
[Sturge-Weber syndrome].Radiologe. 2013 Dec;53(12):1099-103. doi: 10.1007/s00117-013-2554-x. Radiologe. 2013. PMID: 24292369 Review. German.
-
New Trigger for Stroke-like Episode in Sturge-Weber Syndrome: A Case Report.Children (Basel). 2025 Apr 30;12(5):589. doi: 10.3390/children12050589. Children (Basel). 2025. PMID: 40426769 Free PMC article.
References
-
- Melancon JM, Dohil MA, Eichenfield LF. Facial port-wine stain: When to worry? Pediatr Dermatol. 2012;29(1):131–3. - PubMed
-
- Piram M, Lorette G, Sirinelli D, et al. Sturge-Weber syndrome in patients with facial port-wine stain. Pediatr Dermatol. 2012;29(1):32–7. - PubMed
-
- Enjolras O, Riche MC, Merland JJ. Facial port-wine stains and Sturge-Weber syndrome. Pediatrics. 1985;76:48–51. - PubMed
-
- Tallman B, Tan OT, Morelli JG, et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics. 1991;87:323–7. - PubMed
-
- Nabbout R, Juhasz C. Sturge-Weber syndrome. Hand Clin Neurol. 2013;111:315–21. This article addresses the most updated techniques for MRI imagining in Sturge-Weber syndrome. It is important to understand these methods in order to accurately diagnose brain involvement and to prescribe treatment options accordingly. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources